Neurocrine Biosciences Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Direxion Daily Semiconductor Bear 3X Shares trades at $44.71. Which is the better fit depends on your goals.
| NBIX | SOXS | |
|---|---|---|
Market Cap | $17.40B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $180.55 | $1.61K |
52-Week Low | $123.10 | $32.50 |
Enterprise Value | $16.49B | — |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →